{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:14:54Z","timestamp":1781709294024,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2013-CoG"],"award-info":[{"award-number":["ERC-2013-CoG"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007363","name":"City of Hope Foundation","doi-asserted-by":"publisher","award":["24\/13IRP"],"award-info":[{"award-number":["24\/13IRP"]}],"id":[{"id":"10.13039\/100007363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007479","name":"Foundation of the Savings Bank of Padua and Rovigo","doi-asserted-by":"publisher","award":["20\/21FCRMR"],"award-info":[{"award-number":["20\/21FCRMR"]}],"id":[{"id":"10.13039\/100007479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["2021"],"award-info":[{"award-number":["2021"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000783","name":"European Research Executive Agency","doi-asserted-by":"publisher","award":["H2020-MSCA-IF-2018"],"award-info":[{"award-number":["H2020-MSCA-IF-2018"]}],"id":[{"id":"10.13039\/501100000783","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022824","name":"Sanofi Pasteur MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020668","name":"European Research Executive Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ymthe.2025.12.007","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:35:31Z","timestamp":1765326931000},"page":"1854-1866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lentiviral hematopoietic stem cell gene therapy ameliorates GM1-gangliosidosis in mice"],"prefix":"10.1016","volume":"34","author":[{"given":"Linda","family":"Bucciarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Fabris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Accardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Biffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6886-1072","authenticated-orcid":false,"given":"Valentina","family":"Poletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.12.007_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2025.12.007_bib2","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1089\/hum.2019.190","article-title":"Gene-Based Approaches to Inherited Neurometabolic Diseases","volume":"30","author":"Poletti","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.12.007_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.12.007_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0140-6736(21)02017-1","article-title":"Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1\/2 trial and expanded access","volume":"399","author":"Fumagalli","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.12.007_bib5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","article-title":"Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial","volume":"388","author":"Sessa","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.12.007_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi8214","article-title":"Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome","volume":"16","author":"Consiglieri","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.12.007_bib7","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa2106596","article-title":"Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome","volume":"385","author":"Gentner","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.12.007_bib8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41576-020-00298-5","article-title":"Gene therapy using haematopoietic stem and progenitor cells","volume":"22","author":"Ferrari","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2025.12.007_bib9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/blood-2019-128805","article-title":"Extensive Metabolic Correction of Hurler Disease By Hematopoietic Stem Cell-Based Gene Therapy: Preliminary Results from a Phase I\/II Trial","volume":"134","author":"Gentner","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.12.007_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.734878","article-title":"GM1 Gangliosidosis-A Mini-Review","volume":"12","author":"Nicoli","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymthe.2025.12.007_bib11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ymgme.2019.12.012","article-title":"The natural history of Type 1 infantile GM1 gangliosidosis: A literature-based meta-analysis","volume":"129","author":"Lang","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2025.12.007_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0009-9120(00)00049-7","article-title":"Characterization of beta-galactosidase in leukocytes and fibroblasts of GM1 gangliosidosis heterozygotes compared to normal subjects","volume":"33","author":"Sopelsa","year":"2000","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymthe.2025.12.007_bib13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10545-005-0089-7","article-title":"Bone marrow transplantation correcting beta-galactosidase activity does not influence neurological outcome in juvenile GM1-gangliosidosis","volume":"28","author":"Shield","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2025.12.007_bib14","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1182\/blood-2005-03-1189","article-title":"Chemokine-induced recruitment of genetically modified bone marrow cells into the CNS of GM1-gangliosidosis mice corrects neuronal pathology","volume":"106","author":"Sano","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.12.007_bib15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.omtm.2022.04.012","article-title":"Hematopoietic stem cell gene therapy ameliorates CNS involvement in murine model of GM1-gangliosidosis","volume":"25","author":"Tsunogai","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.12.007_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1701211","article-title":"Intracerebroventricular delivery of hematopoietic progenitors results in rapid and robust engraftment of microglia-like cells","volume":"3","author":"Capotondo","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2025.12.007_bib17","doi-asserted-by":"crossref","first-page":"8024","DOI":"10.1038\/s41467-024-52301-w","article-title":"Therapeutic efficacy of intracerebral hematopoietic stem cell gene therapy in an Alzheimer's disease mouse model","volume":"15","author":"Milazzo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.007_bib18","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202215968","article-title":"An innovative hematopoietic stem cell gene therapy approach benefits CLN1 disease in the mouse model","volume":"15","author":"Peviani","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.12.007_bib19","doi-asserted-by":"crossref","first-page":"10035","DOI":"10.1074\/jbc.275.14.10035","article-title":"Processing of lysosomal beta-galactosidase. The C-terminal precursor fragment is an essential domain of the mature enzyme","volume":"275","author":"van der Spoel","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.12.007_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.copbio.2007.01.003","article-title":"Fluorescence imaging in vivo: recent advances","volume":"18","author":"Rao","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.12.007_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/hum.2020.135","article-title":"Conditioning Regimens in Long-Term Pre-Clinical Studies to Support Development of Ex Vivo Gene Therapy: Review of Nonproliferative and Proliferative Changes","volume":"32","author":"Chanut","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.12.007_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.08.021","article-title":"High-titer AAV disrupts cerebrovascular integrity and induces lymphocyte infiltration in adult mouse brain","volume":"31","author":"Guo","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.12.007_bib23","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jconrel.2023.01.067","article-title":"AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges","volume":"355","author":"Kang","year":"2023","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.12.007_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/mt.2013.266","article-title":"AAV9-mediated expression of a non-self protein in nonhuman primate central nervous system triggers widespread neuroinflammation driven by antigen-presenting cell transduction","volume":"22","author":"Samaranch","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.007_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.09.001","article-title":"Breaching the blood-brain barrier: AAV triggers dose-dependent toxicity in the brain","volume":"31","author":"Stone","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.12.007_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25021050","article-title":"Delivery of Adeno-Associated Virus Vectors to the Central Nervous System for Correction of Single Gene Disorders","volume":"25","author":"Daci","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.12.007_bib27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41434-023-00405-1","article-title":"Adeno-associated virus vectors and neurotoxicity-lessons from preclinical and human studies","volume":"32","author":"Stone","year":"2025","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.12.007_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","article-title":"Emerging Issues in AAV-Mediated In Vivo Gene Therapy","volume":"8","author":"Colella","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.12.007_bib29","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ymthe.2020.11.020","article-title":"Update on Clinical Ex Vivo Hematopoietic Stem Cell Gene Therapy for Inherited Monogenic Diseases","volume":"29","author":"Tucci","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.007_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00440","article-title":"Hematopoietic stem cell gene therapy to halt neurodegeneration","volume":"21","author":"Biffi","year":"2024","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ymthe.2025.12.007_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.stem.2023.04.014","article-title":"Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy","volume":"30","author":"Ferrari","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2025.12.007_bib32","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/sctm.16-0358","article-title":"Mechanisms of Tolerance Induction by Hematopoietic Chimerism: The Immune Perspective","volume":"6","author":"Yolcu","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ymthe.2025.12.007_bib33","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ymthe.2004.10.006","article-title":"Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector","volume":"11","author":"Kobayashi","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.007_bib34","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa2405541","article-title":"Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy","volume":"391","author":"Duncan","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.12.007_bib35","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1073\/pnas.1205858109","article-title":"Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation","volume":"109","author":"Capotondo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.12.007_bib36","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3390\/v13081526","article-title":"Designing lentiviral vectors for gene therapy of genetic diseases","volume":"13","author":"Poletti","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2025.12.007_bib37","doi-asserted-by":"crossref","first-page":"13532","DOI":"10.1074\/jbc.RA119.009811","article-title":"Intracerebroventricular enzyme replacement therapy with beta-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice","volume":"295","author":"Chen","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.12.007_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101313","article-title":"A GLB1 transgene with enhanced therapeutic potential for the preclinical development of ex-vivo gene therapy to treat mucopolysaccharidosis type IVB","volume":"32","author":"Crippa","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.12.007_bib39","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ymgme.2011.09.016","article-title":"Murine \u03b2-galactosidase stability is not dependent on temperature or protective protein\/cathepsin A","volume":"104","author":"Lambourne","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2025.12.007_bib40","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/10430340050015617","article-title":"Correction of acid beta-galactosidase deficiency in GM1 gangliosidosis human fibroblasts by retrovirus vector-mediated gene transfer: higher efficiency of release and cross-correction by the murine enzyme","volume":"11","author":"Sena-Esteves","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.12.007_bib41","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1016\/j.cell.2021.06.024","article-title":"Fibroblasts: Origins, definitions, and functions in health and disease","volume":"184","author":"Plikus","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.12.007_bib42","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/1873-3468.13571","article-title":"Emerging lysosomal pathways for quality control at the endoplasmic reticulum","volume":"593","author":"De Leonibus","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymthe.2025.12.007_bib43","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1172\/JCI28873","article-title":"Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice","volume":"116","author":"Biffi","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.12.007_bib44","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ymthe.2024.01.034","article-title":"An empowered, clinically viable hematopoietic stem cell gene therapy for the treatment of multisystemic mucopolysaccharidosis type II","volume":"32","author":"Das","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.007_bib45","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1182\/blood-2010-04-278234","article-title":"Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model","volume":"116","author":"Visigalli","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.12.007_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0047-6374(97)00093-6","article-title":"Evaluation of the activities of eight lysosomal hydrolases in sera of humans, rats and pigs of different ages","volume":"99","author":"Sanchez-Martin","year":"1997","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ymthe.2025.12.007_bib47","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.gim.2021.12.013","article-title":"Measurement of lysosomal enzyme activities: A technical standard of the American College of Medical Genetics and Genomics (ACMG)","volume":"24","author":"Strovel","year":"2022","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymthe.2025.12.007_bib48","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1093\/hmg\/ddv168","article-title":"Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan","volume":"24","author":"Weismann","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.12.007_bib49","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1089\/hum.2018.206","article-title":"A Single Injection of an Optimized Adeno-Associated Viral Vector into Cerebrospinal Fluid Corrects Neurological Disease in a Murine Model of GM1 Gangliosidosis","volume":"31","author":"Hinderer","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.12.007_bib50","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708730","article-title":"Brain-targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms","volume":"10","author":"Gleitz","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.12.007_bib51","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: model systems for human biology and medicine","volume":"21","author":"Kim","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.12.007_bib52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymthe.2017.12.007","article-title":"Hyperactive Factor IX Padua: A Game-Changer for Hemophilia Gene Therapy","volume":"26","author":"VandenDriessche","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.007_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-49908-4","article-title":"CNS Repopulation by hematopoietic-derived microglia-like cells corrects progranulin deficiency","volume":"15","author":"Colella","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.007_bib54","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1182\/bloodadvances.2023010409","article-title":"Donor bone marrow-derived macrophage engraftment into the central nervous system of patients following allogeneic transplantation","volume":"7","author":"Loeb","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2025.12.007_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abl9945","article-title":"Treatment of a genetic brain disease by CNS-wide microglia replacement","volume":"14","author":"Shibuya","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.12.007_bib56","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/hum.2016.068","article-title":"Preclinical Testing of the Safety and Tolerability of Lentiviral Vector-Mediated Above-Normal Alpha-L-Iduronidase Expression in Murine and Human Hematopoietic Cells Using Toxicology and Biodistribution Good Laboratory Practice Studies","volume":"27","author":"Visigalli","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.12.007_bib57","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625010317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625010317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T20:40:26Z","timestamp":1776372026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625010317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1525001625010317"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.12.007","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lentiviral hematopoietic stem cell gene therapy ameliorates GM1-gangliosidosis in mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}